Association Between Physical Status and the Effects of Combination Therapy With Renin-Angiotensin System Inhibitors and β-Blockers in Patients With Acute Heart Failure-Reference-Cited by-同舟云学术

Association Between Physical Status and the Effects of Combination Therapy With Renin-Angiotensin System Inhibitors and β-Blockers in Patients With Acute Heart Failure

Published:2021-04-09 Issue:4 Volume:3 Page:217-226
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Takabayashi Kensuke¹,Kitaguchi Shouji¹,Yamamoto Takashi¹,Fujita Ryoko¹,Takenaka Kotoe¹,Takenaka Hiroyuki¹,Okuda Miyuki²,Nakajima Osamu³,Koito Hitoshi⁴,Terasaki Yuka⁵,Kitamura Tetsuhisa⁶,Nohara Ryuji¹

Affiliation:

1. Department of Cardiology, Hirakata Kohsai Hospital

2. Department of Internal Medicine, Osaka Hospital

3. Department of Cardiology, Hirakata City Hospital

4. Department of Cardiology, Otokoyama Hospital

5. Department of Internal Medicine, Arisawa General Hospital

6. Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/3/4/3_CR-20-0123/_pdf

Reference40 articles.

1. 1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129–2200.

2. 2. Tsutsui H, Isobe M, Ito H, Okumura K, Ono M, Kitakaze M, et al. JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure: Digest version. Circ J 2019; 83: 2084–2184.

3. 3. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62: e147–e239.

4. 4. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J. The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338–2345.

5. 5. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, et al. Irbesartan in Patients with heart failure and preserved ejection fraction. N Eng J Med 2008; 359: 2456–2467.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frailty interferes with the guideline‐directed medical therapy in heart failure patients with reduced ejection fraction;ESC Heart Failure;2022-10-03

2. Is Combination Therapy the Key for Treatment of Heart Failure With Mid-Range or Preserved Ejection Fraction?;Circulation Journal;2022-09-22